GlassScriptPhysician profile
Adrian B Mcclellan
NPI 1336426543
$5,934.55
in general payments reported to CMS, 2019-2025
38 companies · $69.27 in 2025
The $69.27 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,235 · 2022: $1,077 · 2023: $1,545 · 2024: $2,008 · 2025: $69.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,621.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,040.58 | 2021-2024 | Rybelsus, Ozempic, Saxenda |
| Astrazeneca Pharmaceuticals LP | $932.08 | 2021-2024 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $830.05 | 2021-2024 | Mounjaro, Jardiance, Zepbound |
| Dexcom, INC. | $405.96 | 2021-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $309.21 | 2021-2023 | Jardiance, Synjardy |
| Ironwood Pharmaceuticals, INC | $225.70 | 2023-2024 | Linzess |
| Abbvie INC. | $204.24 | 2023-2025 | |
| Axsome Therapeutics, INC. | $200.49 | 2023-2024 | Sunosi |
| Radius Health, INC. | $191.69 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $163.42 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $156.90 | 2023-2024 | Xifaxan, Trulance |
| Astellas Pharma US INC | $154.45 | 2024 | Veozah |
| Pfizer INC. | $120.19 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $92.34 | 2023 | |
| Merck Sharp & Dohme LLC | $86.84 | 2021-2023 | Verquvo, Belsomra, Steglatro |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $82.65 | 2023-2024 | Evenity, Prolia, Repatha |
| Shield Therapeutics INC | $74.74 | 2023-2024 | Accrufer |
| Phathom Pharmaceuticals, INC. | $57.39 | 2024-2025 | Voquezna |
| Abbott Laboratories | $56.10 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $52.28 | 2023-2024 | Rexulti |
| Lundbeck LLC | $51.61 | 2024 | Vyepti |
| Novartis Pharmaceuticals Corporation | $50.83 | 2024 | |
| Exact Sciences Corporation | $50.25 | 2023-2024 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $32.04 | 2023-2024 | Nexletol |
| Takeda Pharmaceuticals U.S.A., INC. | $30.58 | 2023-2024 | Trintellix |
| Atricure, INC. | $28.87 | 2021 | |
| Corcept Therapeutics | $26.51 | 2024 | Korlym |
| Harmony Biosciences LLC | $26.41 | 2023 | Wakix |
| Glaxosmithkline, LLC. | $25.99 | 2023-2024 | Arexvy, Shingrix |
| Regeneron Healthcare Solutions, INC. | $25.14 | 2023 | Evkeeza |
| Ardelyx, INC. | $23.31 | 2024 | Ibsrela |
| Sumitomo Pharma America, INC. | $23.09 | 2024 | Gemtesa |
| Inspire Medical Systems, INC. | $20.39 | 2024 | Inspire |
| Medtronic, INC. | $18.75 | 2024 | Minimed 780g |
| Xeris Pharmaceuticals, INC. | $18.64 | 2023 | Gvoke Hypopen |
| Currax Pharmaceuticals LLC | $17.80 | 2023 | Contrave, Onzetra Xsail |
| Averitas Pharma INC. | $15.83 | 2023 | Qutenza |
| Zealand Pharma US, INC. | $11.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Mcclellan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.